Latest news with #VIC
Miami Herald
3 days ago
- Business
- Miami Herald
Harris Teeter announces store renovations in South Carolina
Harris Teeter announced Tuesday that all 12 of its Charleston, South Carolina, area stores will undergo a refresh. This multimillion-dollar investment from the Kroger-owned grocer, which is currently underway, includes enhancing amenities across the stores' produce, meat and seafood departments as well as installing upgraded finishes and decor, according to the press release. Four of the 12 stores included in the refresh are done, having received "major remodels" that included improvements to self-checkout and putting in new produce displays and expanded food cases. To celebrate the completed remodels, Harris Teeter is reviving its "Taste of Teeter" event across the Charleston area. Each revamped store will host the event upon reopening, with the first celebration taking place on Thursday. The event includes a ribbon-cutting ceremony and complimentary tastings of local products. Harris Teeter's VIC card members will have access to special savings and double fuel points. "This market renovation represents our continued investment in delivering exceptional shopping experiences and celebrates our love for our Lowcountry neighbors," said Danna Robinson, the grocer's director of corporate affairs and customer relations. The announcement noted that Harris Teeter has had a presence in the Lowcountry area for nearly 50 years. Harris Teeter runs more than 250 stores across North Carolina, South Carolina, Virginia, Georgia, Maryland, Delaware, Florida and Washington, D.C. Copyright 2025 Industry Dive. All rights reserved.
Miami Herald
3 days ago
- Business
- Miami Herald
Harris Teeter announces market-wide store renovations
Harris Teeter announced Tuesday that all 12 of its Charleston, South Carolina, area stores will undergo a refresh. This multimillion-dollar investment from the Kroger-owned grocer, which is currently underway, includes enhancing amenities across the stores' produce, meat and seafood departments as well as installing upgraded finishes and decor, according to the press release. Four of the 12 stores included in the refresh are done, having received "major remodels" that included improvements to self-checkout and putting in new produce displays and expanded food cases. To celebrate the completed remodels, Harris Teeter is reviving its "Taste of Teeter" event across the Charleston area. Each revamped store will host the event upon reopening, with the first celebration taking place on Thursday. The event includes a ribbon-cutting ceremony and complimentary tastings of local products. Harris Teeter's VIC card members will have access to special savings and double fuel points. "This market renovation represents our continued investment in delivering exceptional shopping experiences and celebrates our love for our Lowcountry neighbors," said Danna Robinson, the grocer's director of corporate affairs and customer relations. The announcement noted that Harris Teeter has had a presence in the Lowcountry area for nearly 50 years. Harris Teeter runs more than 250 stores across North Carolina, South Carolina, Virginia, Georgia, Maryland, Delaware, Florida and Washington, D.C. Copyright 2025 Industry Dive. All rights reserved.
Yahoo
13-06-2025
- Business
- Yahoo
Life Sciences Investor Forum: Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Investor Forum, held June 11th and 12th are now available for online viewing. REGISTER AND VIEW PRESENTATIONS The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may downloadinvestor materials from the company's resource section. Select companies are accepting 1x1 management meeting requests through June 17. June 11th Presentation Ticker(s) Nika Pharmaceuticals (OTCQB: NIKA) Tivic Health Systems Inc. (NASDAQ: TIVC) Adia Nutrition, Inc. (OTCQB: ADIA) Sandoz Group AG (OTCQX: SDZNY | SIX: SDZ) June 12th Presentation Ticker(s) CSL Ltd. (OTCQX: CSLLY | ASX: CSL) Sharps Technology, Inc. (NASDAQ: STSS) Heidelberg Pharma AG (XETRA: HPHA) SBC Medical Group Holdings Incorporated (NASDAQ: SBC) Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) IMUNON, Inc. (NASDAQ: IMNN) Bio-Path Holdings, Inc. (OTCQB: BPTH) Perimeter Medical Imaging AI, Inc. (OTCQX: PYNKF | TSXV: PINK) MetaVia Inc. (NASDAQ: MTVA) Conavi Medical Corp. (OTCQB: CNVIF | TSXV: CNVI) Vycor Medical, Inc. (OTCQB: VYCO) Envoy Medical, Inc. (NASDAQ: COCH) Starpharma Holdings Ltd. (OTCQX: SPHRY | ASX: SPL) To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit About Virtual Investor Conferences® Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors. Media Contact:OTC Markets Group Inc. +1 (212) 896-4428, media@ Virtual Investor Conferences Contact:John M. ViglottiSVP Corporate Services, Investor AccessOTC Markets Group (212) 220-2221johnv@
Hamilton Spectator
12-06-2025
- Business
- Hamilton Spectator
UPDATE - Nika Pharmaceuticals, Inc. to Present at the Life Sciences Virtual Investor Forum June 11th-12th
HENDERSON, Nev., June 12, 2025 (GLOBE NEWSWIRE) — Nika Pharmaceuticals, Inc. (OTCQB:NIKA), based in Colorado, focused on cures for life-threatening diseases, today announced that Dimitar Savov, CEO, will present live at the Life Sciences Virtual Investor Frum hosted by , on June 11th, 2025 DATE: June 11th TIME: 1:00 PM ET LINK: REGISTER HERE Available for 1x1 meetings: June 12th-17th between 09:00am ET and 11:30am ET This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at . Recent Company Highlights About Nika Pharmaceuticals, Inc. Nika Pharmaceuticals, Inc. (NIKA) is a pharmaceutical company, specializing in the treatment of HIV/AIDS, Hepatitis B and C, Rheumatoid Arthritis, Cancer, Diabetes, and all diseases, for which strengthened cell immunity is of vital importance. NIKA's intellectual property includes six drugs in injection form – two of which have successfully undergone clinical trials with good treatment results – four drugs in tablet form, and eleven dietary supplements. NIKA's goal is to not only achieve corporate profits, but to provide better and easier access to life-saving medicinal drugs and useful dietary supplements. Find more on . Forward-looking Statement: This press release contains forward-looking statements. Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are 'forward- looking statements.' These forward-looking statements generally are identified by the words 'believes,' 'expects,' 'anticipates,'' estimates,' 'intends,' 'strategy,' 'plan,' 'may,' 'will,' 'would,' 'will be,' 'will continue,' 'will likely result,' and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. About Virtual Investor Conferences® Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors. CONTACTS: Nika Pharmaceuticals, Inc. Name Clifford P. Redekop Title Corporate Secretary Phone (702) 326-3615 Email cliffredekop@ Virtual Investor Conferences John M. Viglotti SVP Corporate Services, Investor Access OTC Markets Group (212) 220-2221 johnv@
Yahoo
11-06-2025
- Business
- Yahoo
Conavi Medical to Present at the Life Sciences Virtual Investor Forum June 12th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) ('Conavi Medical' or the 'Company'), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced that Thomas Looby, CEO, will present live at the Life Sciences Virtual Investor Forum hosted by on June 12th, 2025 DATE: June 12th TIME: 2:00 PM ETLINK: REGISTER HERE This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at Recent Company Highlights Upsized $20 million CAD financing led by U.S. institutional investors is expected to support finalizing product development of the next-generation Novasight Hybrid system, submit for regulatory clearance and enable commercial launch New U.S. intracoronary imaging guidelines from the American College of Cardiology and recent peer-reviewed research strongly validate Novasight's unique value proposition U.S. FDA 510(k) submission remains on track for calendar Q3 2025 About Conavi MedicalConavi Medical is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid™ System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. The Novasight Hybrid System has 510(k) clearance from the U.S. Food and Drug Administration; and regulatory approval for clinical use from Health Canada, China's National Medical Products Administration, and Japan's Ministry of Health, Labor and Welfare. For more information, visit About Virtual Investor Conferences®Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors. Forward-Looking StatementsThis press release includes forward-looking information or forward-looking statements within the meaning of applicable securities laws regarding Conavi and its business, which may include, but are not limited to, statements with respect to the anticipated use of proceeds from the April 2025 public offering, Conavi's exposure to the U.S. investment community, the commercialization and development of the Novasight Hybrid System and the achievement and timeline of key milestones towards commercialization and development of the Novasight Hybrid System. All statements that are, or information which is, not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking information or statements". Often but not always, forward-looking information or statements can be identified by the use of words such as "shall", "intends", "anticipate", "believe", "plan", "expect", "intend", "estimate" "anticipate" or any variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "might", "can", "could", "would" or "will" be taken, occur, lead to, result in, or, be achieved. Such statements are based on the current expectations and views of future events of the management of the Company. They are based on assumptions and subject to risks and uncertainties. Although management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release, may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including, without limitation, those listed in the "Risk Factors" section of the short form prospectus dated April 15, 2025 and the joint information circular of the Company dated August 30, 2024 (both of which are on the Company's profile at ). Although Conavi has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Conavi does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or regulatory authority has approved or disapproved the content of this press the TSX Venture Exchange nor its Regulatory Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release. Contacts: Conavi MedicalStefano PiconeChief Financial Officerir@ 483-0100 Virtual Investor Conferences John M. ViglottiSVP Corporate Services, Investor AccessOTC Markets Group (212) 220-2221johnv@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
